| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009531668 |
| P356 | DOI | 10.1038/GT.2010.49 |
| P698 | PubMed publication ID | 20463760 |
| P5875 | ResearchGate publication ID | 44593298 |
| P2093 | author name string | K R Emslie | |
| A Baoutina | |||
| G S Bains | |||
| T Coldham | |||
| P2860 | cites work | Quantification of mRNA using real-time RT-PCR | Q28296375 |
| Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response | Q29619095 | ||
| Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia | Q33713495 | ||
| AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. | Q34168942 | ||
| Combining allele-specific fluorescent probes and restriction assay in real-time PCR to achieve SNP scoring beyond allele ratios of 1:1000. | Q34760338 | ||
| Sports drug testing--an analyst's perspective | Q35635374 | ||
| Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model | Q35847459 | ||
| Potential use of gene transfer in athletic performance enhancement. | Q36902844 | ||
| Gender differences in serotype 2 adeno-associated virus biodistribution after administration to rodent salivary glands | Q36972666 | ||
| Developing strategies for detection of gene doping. | Q37032504 | ||
| Affinity sensing for transgenes detection in antidoping control | Q39781509 | ||
| Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle | Q44474527 | ||
| Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults | Q45409947 | ||
| Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models | Q45873535 | ||
| Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo | Q45878425 | ||
| Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates | Q45880369 | ||
| Gene therapy for lipoprotein lipase deficiency: working toward clinical application | Q45888172 | ||
| Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits | Q47845919 | ||
| Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman Primates. | Q53826123 | ||
| Evaluation of long-term toxicity of Ad/hIFN-, an Adenoviral vector encoding the human interferon-gamma gene, in nonhuman primates | Q64376561 | ||
| Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial | Q74139377 | ||
| Accuracy in amplification | Q77106394 | ||
| P433 | issue | 8 | |
| P921 | main subject | erythropoietin | Q218706 |
| P304 | page(s) | 1022-1032 | |
| P577 | publication date | 2010-05-13 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system | |
| P478 | volume | 17 |
| Q98228260 | A duplex qPCR assay for human erythropoietin (EPO) transgene to control gene doping in horses |
| Q91810112 | A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA |
| Q45872533 | A polymerase chain reaction-based methodology to detect gene doping |
| Q39624185 | A quick one-tube nested PCR-protocol for EPO transgene detection |
| Q46271452 | A real-time in vitro assay to evaluate the release of macromolecules from liposomes |
| Q83259870 | Annual banned-substance review: analytical approaches in human sports drug testing |
| Q38003108 | Detection of EPO gene doping in blood |
| Q38029405 | Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future |
| Q57477784 | Digital PCR detection of plasmid DNA administered to the skeletal muscle of a microminipig: a model case study for gene doping detection |
| Q38738678 | Equine performance genes and the future of doping in horseracing. |
| Q40986812 | Establishment of two quantitative nested qPCR assays targeting the human EPO transgene. |
| Q38119906 | From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? |
| Q83011609 | Gene doping: Olympic genes for Olympic dreams |
| Q36349024 | Genetic doping and health damages. |
| Q38017318 | Human genetic variation: new challenges and opportunities for doping control |
| Q45868167 | Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping |
| Q45873325 | Loop-mediated isothermal amplification (LAMP) as an alternative to PCR: A rapid on-site detection of gene doping |
| Q34361637 | PCR-based detection of gene transfer vectors: application to gene doping surveillance |
| Q37884431 | Recent developments in doping testing for erythropoietin |
| Q54147265 | Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016. |
| Q40641203 | Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy. |
| Q37874460 | The importance of reference materials in doping-control analysis |
| Q34227757 | The use of genes for performance enhancement: doping or therapy? |
| Q34465859 | Transgene detection by digital droplet PCR |
| Q39682186 | Transgene traceability in transgenic mice: a bioanalytical approach for potential gene-doping analysis. |
| Q38020966 | Treating patients with schizophrenia deficit with erythropoietin? |
Search more.